2024
DOI: 10.1080/14737167.2024.2352006
|View full text |Cite
|
Sign up to set email alerts
|

Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review

Sudewi Mukaromah Khoirunnisa,
Fithria Dyah Ayu Suryanegara,
Didik Setiawan
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 95 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?